{"transactions":[{"id":2803606,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":141691,"kind":"person","name":"Hadfield Robert","position":1,"cik":"0001630687","reported_name":"Hadfield Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer and Sec."}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-08T22:29:24.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":326250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/16th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2020."}],"balance_after":326250,"derivative":{"exercise_price":4.31,"expiration_date":"2031-03-04","underlying":"Common Stock","underlying_shares":326250},"source":{"system":"sec-edgar","filing":"0001209191-21-018630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121018630/doc4.xml","form_type":"4"}},{"id":2803605,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":141691,"kind":"person","name":"Hadfield Robert","position":1,"cik":"0001630687","reported_name":"Hadfield Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer and Sec."}}],"security":"Common Stock","published_at":"2021-03-08T22:29:24.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":43500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"10,875 shares shall vest on each of 12/31/2021, 12/31/2022, 12/31/2023 and 12/31/2024."}],"balance_after":176819,"source":{"system":"sec-edgar","filing":"0001209191-21-018630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121018630/doc4.xml","form_type":"4"}},{"id":2909818,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":141691,"kind":"person","name":"Hadfield Robert","position":1,"cik":"0001630687","reported_name":"Hadfield Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-01-12T21:33:45.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":26500,"price":3.12,"value":82680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to satisfy withholding tax obligations upon the vesting of restricted stock grants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.035 to $3.195, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":133319,"source":{"system":"sec-edgar","filing":"0001209191-21-003242","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121003242/doc4.xml","form_type":"4"}},{"id":3296868,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":141691,"kind":"person","name":"Hadfield Robert","position":1,"cik":"0001630687","reported_name":"Hadfield Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-31T21:48:43.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":90800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2019."}],"balance_after":90800,"derivative":{"exercise_price":4.21,"expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":90800},"source":{"system":"sec-edgar","filing":"0001209191-20-005783","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919120005783/doc4.xml","form_type":"4"}},{"id":3296867,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":141691,"kind":"person","name":"Hadfield Robert","position":1,"cik":"0001630687","reported_name":"Hadfield Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2020-01-31T21:48:43.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":59100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"19,700 shares shall vest on each of 12/31/2020, 12/31/2021 and 12/31/2022."}],"balance_after":159819,"source":{"system":"sec-edgar","filing":"0001209191-20-005783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919120005783/doc4.xml","form_type":"4"}},{"id":3323840,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":141691,"kind":"person","name":"Hadfield Robert","position":1,"cik":"0001630687","reported_name":"Hadfield Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2020-01-03T22:07:44.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":16853,"price":4.55,"value":76681.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to satisfy withholding\ntax obligations upon the vesting of restricted stock grants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.46 to $4.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":100719,"source":{"system":"sec-edgar","filing":"0001209191-20-001173","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919120001173/doc4.xml","form_type":"4"}},{"id":3700901,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":141691,"kind":"person","name":"Hadfield Robert","position":1,"cik":"0001630687","reported_name":"Hadfield Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-08T21:25:49.000Z","date":"2019-01-06","kind":"grant","acquired":true,"shares":185391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2018."}],"balance_after":185391,"derivative":{"exercise_price":2.24,"expiration_date":"2029-01-06","underlying":"Common Stock","underlying_shares":185391},"source":{"system":"sec-edgar","filing":"0001209191-19-002782","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919119002782/doc4.xml","form_type":"4"}},{"id":3700900,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":141691,"kind":"person","name":"Hadfield Robert","position":1,"cik":"0001630687","reported_name":"Hadfield Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2019-01-08T21:25:49.000Z","date":"2019-01-06","kind":"grant","acquired":true,"shares":117572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"39,191 shares shall vest on each of 12/31/2019 and 12/31/2020, and 39,190 shares shall vest on 12/31/2021."}],"balance_after":117572,"source":{"system":"sec-edgar","filing":"0001209191-19-002782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919119002782/doc4.xml","form_type":"4"}},{"id":3955157,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":141691,"kind":"person","name":"Hadfield Robert","position":1,"cik":"0001630687","reported_name":"Hadfield Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-04-27T21:21:47.000Z","date":"2018-04-25","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50,000 shares shall vest on each of 4/25/2019, 4/25/2020 and 4/25/2021."}],"balance_after":150000,"derivative":{"exercise_price":4.32,"expiration_date":"2028-04-25","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-18-026654","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919118026654/doc4.xml","form_type":"4"}},{"id":4484969,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":141691,"kind":"person","name":"Hadfield Robert","position":1,"cik":"0001630687","reported_name":"Hadfield Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-20T14:02:56.000Z","date":"2017-01-18","kind":"grant","acquired":true,"shares":57000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 48 successive equal monthly installments measured from January 18, 2017."}],"balance_after":57000,"derivative":{"exercise_price":4.58,"expiration_date":"2027-01-18","underlying":"Common Stock","underlying_shares":57000},"source":{"system":"sec-edgar","filing":"0001615219-17-000007","document":"wf-form4_148492096383173.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521917000007/wf-form4_148492096383173.xml","form_type":"4"}}]}